RSV clinical trials at UCSF
1 research study open to eligible people
RSV is a common respiratory virus that can make breathing hard for infants and older adults. UCSF is running research on azithromycin in children with RSV who need breathing support. UCSF is measuring lung function and infection signs in study participants.
Showing trials for
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
open to eligible people ages up to 2 years
The overarching hypothesis of the ARRC trial is that administration of Azithromycin (AZM) during acute, Respiratory Syncytial Virus (RSV)-induced respiratory failure will be beneficial, mediated through the matrix metalloproteinase (MMP)-9 pathway.
San Francisco, California and other locations
Our lead scientists for RSV research studies include James Howard, MD Matt Zinter, MD.